 Gregory Way
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 10 | 2026 | 669 | 3.300 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2026 | 782 | 2.370 |
Why?
| | Single-Cell Analysis | 3 | 2026 | 361 | 1.860 |
Why?
| | Microscopy | 6 | 2026 | 147 | 1.600 |
Why?
| | Machine Learning | 8 | 2025 | 587 | 1.550 |
Why?
| | Software | 6 | 2026 | 680 | 1.530 |
Why?
| | Gene Expression Profiling | 9 | 2025 | 1777 | 0.930 |
Why?
| | Pyroptosis | 1 | 2025 | 5 | 0.890 |
Why?
| | Transcriptome | 4 | 2025 | 1042 | 0.890 |
Why?
| | Aggression | 3 | 2015 | 180 | 0.790 |
Why?
| | Molecular Imaging | 1 | 2023 | 57 | 0.780 |
Why?
| | Polypharmacology | 1 | 2022 | 2 | 0.720 |
Why?
| | Cells | 1 | 2021 | 25 | 0.660 |
Why?
| | Neurofibromin 1 | 2 | 2019 | 26 | 0.650 |
Why?
| | Cystadenocarcinoma, Serous | 2 | 2024 | 89 | 0.650 |
Why?
| | Data Compression | 1 | 2020 | 8 | 0.630 |
Why?
| | Forecasting | 1 | 2021 | 390 | 0.580 |
Why?
| | Phenotype | 8 | 2026 | 3170 | 0.560 |
Why?
| | Ovarian Neoplasms | 4 | 2024 | 595 | 0.560 |
Why?
| | Zebrafish | 3 | 2025 | 532 | 0.550 |
Why?
| | ras Proteins | 2 | 2019 | 150 | 0.540 |
Why?
| | Glioblastoma | 2 | 2019 | 354 | 0.500 |
Why?
| | Neoplasms | 5 | 2020 | 2913 | 0.500 |
Why?
| | Gene Silencing | 2 | 2018 | 202 | 0.500 |
Why?
| | Algorithms | 7 | 2025 | 1850 | 0.490 |
Why?
| | Gene Expression | 2 | 2021 | 1478 | 0.470 |
Why?
| | Genome-Wide Association Study | 3 | 2025 | 1430 | 0.450 |
Why?
| | Behavior, Animal | 3 | 2015 | 520 | 0.450 |
Why?
| | Genetic Association Studies | 1 | 2016 | 371 | 0.430 |
Why?
| | Genome, Human | 3 | 2025 | 422 | 0.410 |
Why?
| | Reproducibility of Results | 5 | 2026 | 3416 | 0.410 |
Why?
| | Personality | 1 | 2015 | 129 | 0.380 |
Why?
| | Models, Biological | 1 | 2020 | 1764 | 0.370 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2219 | 0.350 |
Why?
| | Cell Line, Tumor | 6 | 2023 | 3551 | 0.320 |
Why?
| | Humans | 30 | 2026 | 145763 | 0.310 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1450 | 0.250 |
Why?
| | Databases, Genetic | 2 | 2018 | 238 | 0.240 |
Why?
| | Apoptosis | 2 | 2025 | 2443 | 0.230 |
Why?
| | Phosphate-Binding Proteins | 1 | 2025 | 6 | 0.220 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2025 | 48 | 0.220 |
Why?
| | DiGeorge Syndrome | 1 | 2025 | 35 | 0.220 |
Why?
| | Chromosome Deletion | 1 | 2025 | 126 | 0.220 |
Why?
| | Craniofacial Abnormalities | 1 | 2025 | 78 | 0.220 |
Why?
| | Caspase 1 | 1 | 2025 | 145 | 0.210 |
Why?
| | Information Storage and Retrieval | 1 | 2025 | 123 | 0.210 |
Why?
| | Quantitative Trait Loci | 2 | 2024 | 381 | 0.210 |
Why?
| | Genomics | 3 | 2025 | 830 | 0.200 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 41 | 0.200 |
Why?
| | Bortezomib | 1 | 2023 | 54 | 0.200 |
Why?
| | Cell Line | 2 | 2021 | 2823 | 0.200 |
Why?
| | Boronic Acids | 1 | 2023 | 36 | 0.200 |
Why?
| | Interleukin-1beta | 1 | 2025 | 389 | 0.190 |
Why?
| | Pyrazines | 1 | 2023 | 94 | 0.190 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 155 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 574 | 0.180 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2025 | 457 | 0.180 |
Why?
| | Imaging, Three-Dimensional | 1 | 2026 | 583 | 0.180 |
Why?
| | Signal Transduction | 4 | 2019 | 5223 | 0.180 |
Why?
| | Budgets | 1 | 2021 | 14 | 0.170 |
Why?
| | Neuroblastoma | 2 | 2020 | 174 | 0.170 |
Why?
| | Interdisciplinary Research | 1 | 2021 | 26 | 0.170 |
Why?
| | High-Throughput Screening Assays | 1 | 2023 | 177 | 0.170 |
Why?
| | Publications | 1 | 2021 | 47 | 0.170 |
Why?
| | Schizophrenia | 1 | 2025 | 464 | 0.170 |
Why?
| | Neoplasm Grading | 2 | 2024 | 311 | 0.160 |
Why?
| | Cell Culture Techniques | 1 | 2023 | 375 | 0.160 |
Why?
| | Bone Development | 1 | 2021 | 52 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 273 | 0.160 |
Why?
| | Animals | 7 | 2026 | 38097 | 0.160 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2020 | 11 | 0.160 |
Why?
| | Biological Assay | 1 | 2021 | 132 | 0.160 |
Why?
| | Supervised Machine Learning | 1 | 2020 | 23 | 0.160 |
Why?
| | Bone Diseases | 1 | 2021 | 61 | 0.160 |
Why?
| | Epigenomics | 1 | 2020 | 117 | 0.150 |
Why?
| | Reward | 1 | 2021 | 248 | 0.150 |
Why?
| | Information Dissemination | 1 | 2021 | 224 | 0.140 |
Why?
| | Mentoring | 1 | 2021 | 166 | 0.140 |
Why?
| | Cooperative Behavior | 1 | 2021 | 463 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2019 | 534 | 0.140 |
Why?
| | Atlases as Topic | 1 | 2018 | 10 | 0.130 |
Why?
| | Bone and Bones | 1 | 2021 | 318 | 0.130 |
Why?
| | Recombinational DNA Repair | 1 | 2018 | 19 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2019 | 274 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 883 | 0.130 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 23 | 0.130 |
Why?
| | Acid Phosphatase | 1 | 2017 | 14 | 0.130 |
Why?
| | Biomedical Technology | 1 | 2018 | 50 | 0.130 |
Why?
| | Bone Density | 2 | 2021 | 487 | 0.130 |
Why?
| | Phosphoproteins | 1 | 2019 | 337 | 0.130 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 177 | 0.130 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2017 | 80 | 0.130 |
Why?
| | Systems Biology | 1 | 2018 | 68 | 0.130 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2017 | 92 | 0.130 |
Why?
| | GTPase-Activating Proteins | 1 | 2017 | 81 | 0.130 |
Why?
| | Nonlinear Dynamics | 1 | 2018 | 93 | 0.130 |
Why?
| | Motivation | 1 | 2021 | 602 | 0.120 |
Why?
| | Bayes Theorem | 1 | 2018 | 421 | 0.120 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 936 | 0.120 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 297 | 0.120 |
Why?
| | Proteomics | 2 | 2021 | 1188 | 0.120 |
Why?
| | Genetic Loci | 1 | 2017 | 267 | 0.120 |
Why?
| | Multiple Myeloma | 1 | 2019 | 309 | 0.120 |
Why?
| | Cichlids | 1 | 2015 | 4 | 0.120 |
Why?
| | Cluster Analysis | 1 | 2016 | 501 | 0.110 |
Why?
| | Models, Genetic | 1 | 2018 | 527 | 0.110 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 318 | 0.110 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 735 | 0.110 |
Why?
| | Video Recording | 1 | 2015 | 219 | 0.100 |
Why?
| | DNA Methylation | 1 | 2017 | 690 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2399 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 719 | 0.080 |
Why?
| | Chromosome Mapping | 2 | 2024 | 507 | 0.080 |
Why?
| | Female | 8 | 2024 | 79035 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2019 | 1331 | 0.080 |
Why?
| | Mutation | 4 | 2025 | 4090 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2015 | 789 | 0.070 |
Why?
| | Molecular Sequence Annotation | 2 | 2019 | 106 | 0.070 |
Why?
| | Chromatin | 2 | 2021 | 553 | 0.060 |
Why?
| | Child | 3 | 2021 | 22739 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2393 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 1247 | 0.050 |
Why?
| | Male | 5 | 2021 | 73003 | 0.050 |
Why?
| | Cell Shape | 1 | 2024 | 56 | 0.050 |
Why?
| | Cell Adhesion | 1 | 2025 | 451 | 0.050 |
Why?
| | Mutant Proteins | 1 | 2024 | 105 | 0.050 |
Why?
| | Neural Stem Cells | 1 | 2025 | 168 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 166 | 0.050 |
Why?
| | Astrocytes | 1 | 2025 | 228 | 0.050 |
Why?
| | Alleles | 1 | 2025 | 896 | 0.050 |
Why?
| | Zebrafish Proteins | 1 | 2025 | 314 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2024 | 588 | 0.040 |
Why?
| | Osteoblasts | 1 | 2021 | 145 | 0.040 |
Why?
| | Antigens, CD20 | 1 | 2019 | 34 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 139 | 0.040 |
Why?
| | Gene Editing | 1 | 2021 | 89 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2019 | 65 | 0.040 |
Why?
| | Osteogenesis | 1 | 2021 | 204 | 0.040 |
Why?
| | Osteosarcoma | 1 | 2019 | 89 | 0.040 |
Why?
| | Wilms Tumor | 1 | 2019 | 90 | 0.030 |
Why?
| | Mitochondria | 1 | 2025 | 992 | 0.030 |
Why?
| | Sarcoma, Ewing | 1 | 2019 | 103 | 0.030 |
Why?
| | Genes, Neoplasm | 1 | 2018 | 26 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2025 | 1166 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2018 | 52 | 0.030 |
Why?
| | Gene Ontology | 1 | 2018 | 54 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 308 | 0.030 |
Why?
| | False Positive Reactions | 1 | 2018 | 123 | 0.030 |
Why?
| | Disease | 1 | 2018 | 96 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2018 | 133 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 171 | 0.030 |
Why?
| | Drug Design | 1 | 2018 | 175 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 447 | 0.030 |
Why?
| | Adult | 1 | 2020 | 40872 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2017 | 188 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1139 | 0.030 |
Why?
| | Neurons | 1 | 2025 | 1652 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 383 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 259 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2018 | 751 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2021 | 740 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 322 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2018 | 474 | 0.030 |
Why?
| | Precision Medicine | 1 | 2019 | 461 | 0.030 |
Why?
| | Sexual Behavior, Animal | 1 | 2015 | 59 | 0.030 |
Why?
| | DNA Damage | 1 | 2018 | 437 | 0.030 |
Why?
| | Histones | 1 | 2020 | 666 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1062 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1474 | 0.020 |
Why?
| | Computer Simulation | 1 | 2018 | 1003 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2181 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 981 | 0.020 |
Why?
| | Brain | 1 | 2025 | 2969 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 693 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2018 | 947 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 982 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2018 | 1202 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5922 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4568 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11868 | 0.010 |
Why?
| | Aged | 1 | 2024 | 26215 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14251 | 0.010 |
Why?
| | Mice | 1 | 2019 | 18355 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 36302 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22573 | 0.010 |
Why?
|
|
Way's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|